Scarica l'app Stockscreener
0.2564
2.73%
-0.0072
Dopo l'orario di chiusura:
.26
0.0036
+1.40%
Precedente Chiudi:
$0.2636
Aprire:
$0.264
Volume 24 ore:
2.31M
Relative Volume:
0.47
Capitalizzazione di mercato:
$29.96M
Reddito:
-
Utile/perdita netta:
$-27.11M
Rapporto P/E:
-0.3945
EPS:
-0.65
Flusso di cassa netto:
$-26.55M
1 W Prestazione:
+0.55%
1M Prestazione:
-21.11%
6M Prestazione:
-44.26%
1 anno Prestazione:
-86.29%
Intervallo 1D:
$0.2549
$0.2679
Intervallo di 1 settimana:
$0.2549
$0.307
Portata 52W:
$0.25
$1.90
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Nome
Reviva Pharmaceuticals Holdings Inc
Settore
Industria
Telefono
(408) 501-8881
Indirizzo
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.2564 | 30.80M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-29 | Iniziato | Chardan Capital Markets | Buy |
| 2023-09-20 | Iniziato | ROTH MKM | Buy |
| 2023-06-08 | Iniziato | The Benchmark Company | Speculative Buy |
| 2022-01-24 | Iniziato | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Borsa (RVPH) Ultime notizie
Price Action: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant a good ESG investmentGlobal Markets & Weekly High Return Stock Forecasts - baoquankhu1.vn
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs in weak economy2025 Volume Leaders & Free Expert Approved Momentum Trade Ideas - mfd.ru
Published on: 2026-02-02 10:12:16 - baoquankhu1.vn
Rate Hike: What is the next catalyst for TLYSMarket Trend Summary & AI Driven Price Forecasts - baoquankhu1.vn
Aug Gainers: How sensitive is Reviva Pharmaceuticals Holdings Inc Equity Warrant to inflationBond Market & Verified Momentum Stock Ideas - baoquankhu1.vn
Retail Trends: What’s the fair value of OSIS stockMarket Sentiment Review & AI Driven Price Predictions - baoquankhu1.vn
Aug Selloffs: Can Reviva Pharmaceuticals Holdings Inc deliver alphaWeekly Trade Recap & Capital Protection Trading Alerts - baoquankhu1.vn
Guidance Update: Is TLRY a good stock for dollar cost averagingTrade Risk Summary & Target Return Focused Stock Picks - baoquankhu1.vn
Published on: 2026-01-30 02:52:59 - baoquankhu1.vn
Breakout Watch: Does Franklin Wireless Corp have declining or rising EPSEarnings Overview Summary & Smart Investment Allocation Tips - baoquankhu1.vn
Market Leaders: Will DXPRC outperform tech stocks2025 Fundamental Recap & Low Volatility Stock Recommendations - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Tonix Pharma (TNXP), Revolution Medicines (RVMD) and Bausch Health Companies (BHC) - The Globe and Mail
Gainers Report: What analysts say about Reviva Pharmaceuticals Holdings Inc stockInsider Buying & Low Volatility Stock Suggestions - baoquankhu1.vn
Chart Watch: Does BlackRock Science and Technology Trust have declining or rising EPSJuly 2025 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Aug Volume: Is ProShares Trust ProShares UltraShort Real Estate exposed to political risk2025 AllTime Highs & Long-Term Capital Growth Ideas - baoquankhu1.vn
Reviva Pharmaceuticals Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Moving Averages: Can IGNEP be the next market leaderWeekly Trend Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Aug EndMonth: What analysts say about Reviva Pharmaceuticals Holdings Inc stockEarnings Overview Summary & Low Risk Entry Point Tips - baoquankhu1.vn
Support Test: What makes Reviva Pharmaceuticals Holdings Inc stock attractive today2025 Market WrapUp & AI Driven Stock Movement Reports - baoquankhu1.vn
Trade Report: Is now the right time to enter Reviva Pharmaceuticals Holdings IncEarnings Recap Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
Technical Analysis: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant withstand a market correction2025 Dividend Review & Precise Swing Trade Alerts - baoquankhu1.vn
Market Outlook: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant stock showing strong momentumJuly 2025 Setups & Low Risk Investment Opportunities - baoquankhu1.vn
RVPH: Brilaroxazine delivers strong efficacy and safety in schizophrenia, with NDA submission targeted for 2027 - TradingView
Sentiment Watch: How sensitive is Reviva Pharmaceuticals Holdings Inc Equity Warrant to inflationEarnings Growth Report & Stepwise Trade Signal Guides - baoquankhu1.vn
Sectors Review: Will Reviva Pharmaceuticals Holdings Inc benefit from green energy policiesJuly 2025 Spike Watch & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Aug Levels: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant stock a top pick in earnings season2025 Fundamental Recap & Low Drawdown Momentum Ideas - Bộ Nội Vụ
Breakouts Watch: How Reviva Pharmaceuticals Holdings Inc stock reacts to Fed rate cutsWeekly Stock Analysis & Community Consensus Trade Alerts - Bộ Nội Vụ
Profit Recap: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant withstand a market correctionAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Reviva Pharmaceuticals Holdings (RVPH) Records 37% in 2026 So far - Finviz
Reviva Pharmaceuticals Holdings (RVPH) Records 37% Gain So far in 2026 - Yahoo Finance
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock deliver sustainable ROEQuarterly Earnings Summary & Fast Entry Momentum Trade Alerts - ulpravda.ru
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock a top pick in earnings seasonJuly 2025 Weekly Recap & High Conviction Trade Alerts - Улправда
Aug Opening: How strong is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock revenue growth2025 Fundamental Recap & Long-Term Investment Growth Plans - Улправда
symbol__ Stock Quote Price and Forecast - CNN
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock benefits from tech adoptionRate Cut & Entry and Exit Point Strategies - Улправда
Is Reviva Pharmaceuticals Holdings Inc. stock trading near support levels2025 Market Outlook & High Yield Equity Trading Tips - Улправда
How strong is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock revenue growth2025 Fundamental Recap & Long-Term Investment Growth Plans - Улправда
Will Tonix Pharmaceuticals Holding Corp. stock see insider buyingTrade Volume Report & Smart Allocation Stock Tips - Улправда
Reviva Pharmaceuticals Holdings, Inc. Announces Publication on Clinical Vocal Biomarker Data from the Recover Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia - marketscreener.com
Aug PreEarnings: How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock benefits from tech adoption2025 Macro Impact & Weekly Chart Analysis and Trade Guides - ulpravda.ru
Will Reviva Pharmaceuticals Holdings Inc. stock maintain dividend yield2025 Retail Activity & Daily Profit Maximizing Trade Tips - ulpravda.ru
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia - The Manila Times
Reviva Announces Publication on Clinical Vocal Biomarker - GlobeNewswire
Study links speech delays to schizophrenia symptoms, may cut trial sizes - Stock Titan
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock continue dividend increases - Улправда
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock continue upward trendBlue Chip Stock Analysis & Free Long-Term Investment Planning - Улправда
Worth Investment Trading Company Limited Shows Risk Reward Favoring Upside - Early Times
Reviva Pharmaceuticals Holdings (RVPH) Receives a Buy from Chardan Capital - The Globe and Mail
Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating - Investing.com Canada
Volatility Watch: Will Reviva Pharmaceuticals Holdings Inc Equity Warrant stock attract ESG investorsJuly 2025 Chart Watch & Verified Stock Trade Ideas - Bộ Nội Vụ
Reviva Pharmaceuticals Holdings Inc Azioni (RVPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):